NYR Ann: Nyrada PCSK9 Inhibitor Tested in Model of Atherosclerosis - 20th Jul 2022, 8:19am

annb0t

annb0t

Top 20
NYR Ann: Nyrada PCSK9 Inhibitor Tested in Model of Atherosclerosis
Price Sensitive: Y
Date: 20th Jul 2022, 8:19am

>>> Read announcement: Google: NYR Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
NYR Ann: Nyrada Review of Operating Costs - 20th Jul 2023, 8:23am
Replies
0
Views
75
annb0t
annb0t
annb0t
NYR Ann: Nyrada Half Year Results FY2023 - 24th Feb 2023, 10:47am
Replies
0
Views
126
annb0t
annb0t
annb0t
NYR Ann: Nyrada AGM 2022 Chairmans Address - 21st Nov 2022, 8:22am
Replies
0
Views
126
annb0t
annb0t
annb0t
NYR Ann: Nyrada Receives A$1.2M R&D Tax Incentive Rebate - 18th Nov 2022, 8:21am
Replies
0
Views
157
annb0t
annb0t
annb0t
NYR Ann: Nyrada Reports Full Year FY2022 Results - 29th Aug 2022, 6:17pm
Replies
0
Views
152
annb0t
annb0t
Top Bottom